Recent advances in managing hepatitis B

In the past two years, several national and international bodies have made recommendations and published updated practice guidelines for hepatitis B. In addition, new drugs have become available for treatment of hepatitis B. This article will review the new recommendations for screening for hepatiti...

Descripción completa

Detalles Bibliográficos
Autor principal: McMahon, Brian J
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports Ltd 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948380/
https://www.ncbi.nlm.nih.gov/pubmed/20948875
http://dx.doi.org/10.3410/M2-11
_version_ 1782187458006351872
author McMahon, Brian J
author_facet McMahon, Brian J
author_sort McMahon, Brian J
collection PubMed
description In the past two years, several national and international bodies have made recommendations and published updated practice guidelines for hepatitis B. In addition, new drugs have become available for treatment of hepatitis B. This article will review the new recommendations for screening for hepatitis B and for first-line antiviral medications to use for treatment. In addition, I will discuss the recent recommendations on treating hepatitis B and human immunodeficiency virus co-infection and the screening of people receiving immunosuppressive therapy.
format Text
id pubmed-2948380
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medicine Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29483802010-10-14 Recent advances in managing hepatitis B McMahon, Brian J F1000 Med Rep Review Article In the past two years, several national and international bodies have made recommendations and published updated practice guidelines for hepatitis B. In addition, new drugs have become available for treatment of hepatitis B. This article will review the new recommendations for screening for hepatitis B and for first-line antiviral medications to use for treatment. In addition, I will discuss the recent recommendations on treating hepatitis B and human immunodeficiency virus co-infection and the screening of people receiving immunosuppressive therapy. Medicine Reports Ltd 2010-02-11 /pmc/articles/PMC2948380/ /pubmed/20948875 http://dx.doi.org/10.3410/M2-11 Text en © 2010 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
McMahon, Brian J
Recent advances in managing hepatitis B
title Recent advances in managing hepatitis B
title_full Recent advances in managing hepatitis B
title_fullStr Recent advances in managing hepatitis B
title_full_unstemmed Recent advances in managing hepatitis B
title_short Recent advances in managing hepatitis B
title_sort recent advances in managing hepatitis b
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948380/
https://www.ncbi.nlm.nih.gov/pubmed/20948875
http://dx.doi.org/10.3410/M2-11
work_keys_str_mv AT mcmahonbrianj recentadvancesinmanaginghepatitisb

Ejemplares similares